For the next stage of the AI era, companies with purposeful, practical, and highly targeted solutions stand to benefit the most.
The company is ambitious and exploring exciting areas, but it's still early in the game.
This biotech is on the verge of a groundbreaking innovation, but it might not get over the hump.
Are the analysts right about these Nvidia-backed AI stocks?
SoundHound AI, Arm, Nano-X, Recursion, and TuSimple are all in Nvidia's portfolio.
AI is rapidly transforming the healthcare industry. Evolving companies such as Intuitive Surgical and Recursion Pharmaceuticals can capitalize on this opportunity.
Check out why SoundHound AI's stock dropped in June, despite a complete lack of negative news. Is this AI stock a great buy today?
Down 76% from all-time highs, is this AI-powered drug stock a good buy right now?
These under-the-radar companies may offer greater long-term rewards.
The CEO has set a high bar for the business, and if it hits it, the stock could easily 10x in value.